Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: Mar 9, 2026, 4:00 PM EDT
1.150
+0.010 (0.88%)
After-hours: Mar 9, 2026, 4:56 PM EDT

Boundless Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17.8726.5923.7110.9534.29
Short-Term Investments
89.71125.5397.0555.7738.74
Cash & Short-Term Investments
107.58152.11120.7566.7273.03
Cash Growth
-29.28%25.97%80.99%-8.65%-
Prepaid Expenses
2.032.283.451.321.54
Total Current Assets
109.61154.39124.268.0474.57
Property, Plant & Equipment
46.8851.364.587.733.1
Long-Term Investments
----34.99
Other Long-Term Assets
0.570.661.121.071.07
Total Assets
157.06206.41129.8976.83113.72
Accounts Payable
6.731.272.221.41.08
Accrued Expenses
2.646.864.943.92.08
Current Portion of Leases
3.17-2.22.340.38
Other Current Liabilities
---0.090.34
Total Current Liabilities
12.548.149.367.733.87
Long-Term Leases
45.8747.63-2.85-
Other Long-Term Liabilities
---0.010.1
Total Liabilities
58.4155.779.3610.583.96
Common Stock
00-00
Additional Paid-In Capital
358.26351.998.995.382.76
Retained Earnings
-259.67-201.47-136.11-86.68-40.77
Comprehensive Income & Other
0.060.120.04-0.4-0.18
Total Common Equity
98.65150.64-127.08-81.7-38.19
Shareholders' Equity
98.65150.64120.5466.25109.76
Total Liabilities & Equity
157.06206.41129.8976.83113.72
Total Debt
49.0447.632.25.180.38
Net Cash (Debt)
58.55104.48118.5661.5372.66
Net Cash Growth
-43.96%-11.87%92.67%-15.31%-
Net Cash Per Share
2.626.1597.5056.0584.43
Filing Date Shares Outstanding
22.4122.31.251.130.86
Total Common Shares Outstanding
22.4122.31.251.130.86
Working Capital
97.07146.26114.8560.3170.7
Book Value Per Share
4.406.76-102.02-71.99-44.38
Tangible Book Value
98.65150.64-127.08-81.7-38.19
Tangible Book Value Per Share
4.406.76-102.02-71.99-44.38
Machinery
-7.055.254.693.7
Leasehold Improvements
-0.980.050.050.2
Source: S&P Capital IQ. Standard template. Financial Sources.